Clinical Trials Logo
  1. Home
  2. Colorectal Cancer
  3. NCT01549067
  4. Details
NCT01549067 Clinical Trial

The Real Clinical Background of Advanced Colorectal Cancer Treatment Situation Survey

Colorectal Cancer Clinical Trial

— Sprit  

Official title:
The Real Clinical Background of Advanced Colorectal Cancer Treatment Situation Survey

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT01549067
Other study ID # Sprit
Secondary ID
Status Recruiting
Phase N/A
First received March 6, 2012
Last updated March 13, 2012
Start date September 2011
Est. completion date December 2012

Study information
Verified date March 2012
Source Chinese Medical Doctor Association
Contact Lin Shen, MD
Phone 010-88140650
Email lin100@medmail.com.cn
Is FDA regulated No
Health authority China: Ethics Committee
Study type Observational

Clinical Trial Summary

Collect the real clinical background of advanced colorectal cancer c of China.

Description:

The Primary Objectives of this study is collect the real clinical background of advanced colorectal cancer treatment situation of China. The Secondary Objectives is the mutation of K-ras , targeting therapy , use present situation of cetuximab and liver metastases treatment situation of colorectal cancer patients.

Recruitment information / eligibility
Status Recruiting
Enrollment 3700
Est. completion date December 2012
Est. primary completion date December 2012
Accepts healthy volunteers No
Gender Both
Age group N/A and older
Eligibility Inclusion Criteria:

- Patients with histologically or cytologically confirmed diagnosis of metastatic colorectal cancer.

Exclusion Criteria:

- Patients with histologically or cytologically confirmed diagnosis other than metastatic colorectal cancer.

Study Design

Time Perspective: Cross-Sectional

Related Conditions & MeSH terms

Locations
Country Name City State
China Peking University Cancer Hospital Beijing Beijing
China Sun Yat-sen University Cancer Center Zhongshan Guangzhou

Sponsors (1)
Lead Sponsor Collaborator
Chinese Medical Doctor Association

Country where clinical trial is conducted

China, 

See also
  Status Clinical Trial Phase
Recruiting NCT05400122 - Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer Phase 1
Active, not recruiting NCT05551052 - CRC Detection Reliable Assessment With Blood
Completed NCT00098787 - Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer Phase 2
Recruiting NCT06037954 - A Study of Mental Health Care in People With Cancer N/A
Recruiting NCT05425940 - Study of XL092 + Atezolizumab vs Regorafenib in Subjects With Metastatic Colorectal Cancer Phase 3
Suspended NCT04595604 - Long Term Effect of Trimodal Prehabilitation Compared to ERAS in Colorectal Cancer Surgery. N/A
Completed NCT03414125 - Effect of Mailed Invites of Choice of Colonoscopy or FIT vs. Mailed FIT Alone on Colorectal Cancer Screening N/A
Completed NCT02963831 - A Study to Investigate ONCOS-102 in Combination With Durvalumab in Subjects With Advanced Peritoneal Malignancies Phase 1/Phase 2
Recruiting NCT05489211 - Study of Dato-Dxd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03) Phase 2
Terminated NCT01847599 - Educational Intervention to Adherence of Patients Treated by Capecitabine +/- Lapatinib N/A
Completed NCT05799976 - Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure N/A
Recruiting NCT03874026 - Study of Folfiri/Cetuximab in FcGammaRIIIa V/V Stage IV Colorectal Cancer Patients Phase 2
Active, not recruiting NCT03170960 - Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors Phase 1/Phase 2
Completed NCT03181334 - The C-SPAN Coalition: Colorectal Cancer Screening and Patient Navigation N/A
Completed NCT03167125 - Participatory Research to Advance Colon Cancer Prevention N/A
Recruiting NCT04258137 - Circulating DNA to Improve Outcome of Oncology PatiEnt. A Randomized Study N/A
Recruiting NCT05568420 - A Study of the Possible Effects of Medication on Young Onset Colorectal Cancer (YOCRC)
Recruiting NCT02972541 - Neoadjuvant Chemotherapy Verse Surgery Alone After Stent Placement for Obstructive Colonic Cancer N/A
Completed NCT02876224 - Study of Cobimetinib in Combination With Atezolizumab and Bevacizumab in Participants With Gastrointestinal and Other Tumors Phase 1
Completed NCT01943500 - Collection of Blood Specimens for Circulating Tumor Cell Analysis N/A